The Filing Desk

PROCEPT BioRobotics vs SkinHealth Systems

PROCEPT BioRobotics PRCT · SkinHealth Systems SKIN · Health Care Equipment

PROCEPT BioRobotics reported revenue of $308 million in fiscal 2025, about the same as SkinHealth Systems' $301 million in fiscal 2025. PROCEPT BioRobotics' revenue grew 37.2% in its latest year, and SkinHealth Systems' fell 10.0%. PROCEPT BioRobotics had an operating margin of -33.7%, against -6.9% at SkinHealth Systems. Free cash flow was −$58 million at PROCEPT BioRobotics and $37 million at SkinHealth Systems.

Side by side

PROCEPT BioRoboticsSkinHealth Systems
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$308M$301M
Revenue growth37.2%−10.0%
Revenue growth a year, last 5 years109.1%20.4%
Gross margin63.7%65.3%
Operating margin−33.7%−6.9%
Net margin−31.0%−3.2%
Free cash flow−$58M$37M
Free cash flow margin−18.9%12.4%
Return on capital−65.4%−7.7%
Net debt to EBITDA—3,991.4x
Dividends and buybacks$0M$0M
Change in diluted share count6.6%−4.7%
Last close$25.75$12.15
P/E at the last close——
Insider trades, last 12 monthsbought $11.0 million, sold $616,004—
Piotroski F-score5 of 97 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
PROCEPT BioRoboticsSkinHealth Systems
Operating margin
Percent of revenue
PROCEPT BioRoboticsSkinHealth Systems
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
PROCEPT BioRoboticsSkinHealth Systems

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the PROCEPT BioRobotics and SkinHealth Systems pages.